655000L060216 |enzyme nscriptase

Ended Awarded Last action

Contract number
HHSN263NDX94610
Awardee
Awarding agency
Obligated
$8,663

Award facts

Contract value
  • $8,662.61 Current, with exercised options
  • $0.00 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Not on record Potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
0 offers Simplified Acquisition
Pricing
Other
Place of performance
MONTGOMRY VLG, MD 20877, USA

Award details come from SAM.gov/FPDS.

Quick answers

Who was awarded contract HHSN263NDX94610?

HHSN263NDX94610 was awarded to Roche Diagnostics Corporation by Office of the Director (National Institutes of Health) on June 29, 2006.

How much is contract HHSN263NDX94610 worth?

The government has obligated $8,663 on HHSN263NDX94610.

Is contract HHSN263NDX94610 an order under another contract?

Yes. HHSN263NDX94610 is a BPA call under GS24F1283C-HHSN263199900051732B, a blanket purchase agreement.

Was contract HHSN263NDX94610 competed?

The government received 0 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award